CENTOGENE Webinar Header Person in Front of a Screen

Illumina and CENTOGENE

Using NIPT to Screen for the Most Common Fetal Chromosomal Abnormalities

July 24, 2017
3 p.m. CEST

Watch on demand

Using NIPT To Screen for the Most Common Fetal Chromosomal Abnormalities

Illumina VeriSeq™ NIPT Solution*

CENTOGENE has a new addition to its prenatal portfolio: CentoNIPT®, its innovative non-invasive prenatal testing that provides a fast and accurate screening for the most common prenatal chromosomal abnormalities (Trisomy 21, Trisomy 18, Trisomy 13 and sex chromosomes).

CentoNIPT® combines next generation sequencing with integrated measurement of fetal fraction, even when the fetal fraction is less than 4%. Based on the Illumina Verifi Prenatal Test & VeriSeq™ NIPT solution, CentoNIPT® promises the lowest test failure rate among NIPT technologies on market (30 – 50 % lower).

Webinar Content

  • Introduction to NIPT and difference with classic prenatal testing
  • Methodology/technology
  • Pre-test and post-test counseling considerations
  • Report example – CENTOGENE base

Notation: *Sample Preparation and analysis software are CE-IVD marked.

Our Speakers

CENTOGENE Webinar Speaker Kristin Dalton

Kristin Dalton

Genetic Counselor at Illumina

Kristin Dalton, a licensed and certified Genetic Counselor, joined Illumina's […]

CENTOGENE Webinar Speaker Peter Bauer

Prof. Peter Bauer, M.D.

Chief Genomic Officer, CENTOGENE

Prof. Peter Bauer, M.D., serves as CENTOGENE’s Chief Genomic Officer, where he combines […]

CENTOGENE Webinar CentoTalk Person in front of a Computer

Load content from Youtube?

By agreeing to load this content i accept to have my information shared with content provider (and it's partners). More info in our Privacy Policy.

Load content
CENTOGENE Webinars CentoTalk Header Person Infront of a Screen

Watch Our CentoTalks on demand

Our interactive webinars that feature key developments in clinical diagnostics.

All recorded webinars